Semin Neurol 2008; 28(4): 558-569
DOI: 10.1055/s-0028-1083692
© Thieme Medical Publishers

Neuroimaging of Pediatric Diseases

Leena M. Ketonen1 , Leena Valanne2
  • 1Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • 2Helsinki Medical Imaging Center, Helsinki University Hospital, Helsinki, Finland
Further Information

Publication History

Publication Date:
08 October 2008 (online)

ABSTRACT

Imaging of the pediatric brain is challenging. Knowledge of the normal anatomy and appearance of the developing brain at a given age is critical in identifying abnormalities. Brain malformations had been in the domain of the neuropathologist, but with advanced neuroimaging they can be defined in vivo. Phacomatoses have a similar tendency to produce manifestations in the central nervous system and many other tissues. The inborn errors of metabolism are a heterogeneous group of rare diseases with diverse imaging findings. In addition to anatomical magnetic resonance (MR) imaging, metabolic imaging with MR spectroscopy is established in many brain disorders, such as tumors, leukodystrophies, and metabolic conditions. Even though catheter angiography remains the gold standard, MR and computed tomography angiography provide rapid and noninvasive alternatives to evaluate children with vascular lesions. This article presents the classic imaging findings in pediatric neurology, including the commonly seen malformations, metabolic disorders, and trauma in addition to some rarer diseases.

REFERENCES

  • 1 Barkovich J A. Pediatric Neuroimaging. 3rd ed. Lippincott Williams & Wilkins Philadephia, Baltimore, New York; 2000
  • 2 Ketonen L M, Hiwatashi A, Sidhu R, Westesson P-L. Pediatric Brain and Spine. An Atlas of MRI and Spectroscopy. Springer; Berlin, Heidelberg, New York 2004
  • 3 Smirniotopoulos J G. Neuroimaging of phakomatoses: Sturge-Weber syndrome, tuberous sclerosis, von Hippel-Lindau syndrome.  Neuroimaging Clin N Am. 2004;  14 171-183
  • 4 Van der Knaap M, Valk J. Magnetic Resonance of Myelination and Myelin Disorders. 3rd ed. Springer; Berlin, Heidelberg, New York 2005
  • 5 Parry A, Matthews P. Roles for imaging in understanding the pathophysiology, clinical evaluation and management of patients with mitochondrial disease.  J Neuroimaging. 2003;  13 293-302
  • 6 Covarrubias D J, Luetmer P H, Campeau N G. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.  AJNR Am J Neuroradiol. 2002;  23 1038-1048
  • 7 Konishi E, Ibayashi N, Yamamoto S, Scheithauer B W. Isolated intracranial Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy).  AJNR Am J Neuroradiol. 2003;  24 515-518

Leena M KetonenM.D. Ph.D. 

Diagnostic Imaging, The University of Texas

M. D. Anderson Cancer Center, 1515 Holcombe Blvd., #370, Houston, TX 77030

Email: leena.ketonen@di.mdacc.tmc.edu

    >